Time Restricted Eating During Chemotherapy for Breast Cancer
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT05259410
- Status
- Recruiting
Conditions
- Breast Cancer Female
Eligibility Criteria
- Sex
- FEMALE
- Age
- 25 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- TRE — BEHAVIORALAll food eaten within the same self-selected 8 hour eating window daily, water fasting the remaining hours of the day.
- MedTRE — BEHAVIORALA mediterranean style diet will be eaten within the same self-selected 8 hour eating window daily, water fasting the remaining hours of the day.
Study Details
Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related outcomes, and limit treatment related weight gain and fat mass accretion.Time restricted eating combined with a mediterranean diet will also be feasible and improve cardiometabolic risk more than TRE alone or standard care.
Key Dates
- Start date
- Aug 1, 2022
- Status verified
- Feb 2025
- Primary completion
- Mar 1, 2026
- Completion
- Mar 1, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Time restricted eatingParticipants will eat all food within the same self selected 8 hour window daily.
- No Intervention: Standard careCurrent standard care is to eat enough calories and protein to maintain weight and lean mass.
- Experimental: Med TREParticipants will eat a mediterranean style diet within the same self selected 8 hour window daily.
Primary Outcome Measure
Feasibility 8-h TRE [ Time Frame: 12 weeks ]
Central Contacts
- Kelsey Gabel, PhD312-413-8911
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Chicago | Chicago | Illinois | 60612 | Kelsey Gabel, PhD |
Find similar trials in Chicago, IL
By research site
Related Studies
- Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRIRecruiting · University of Rochester · Rochester, New York
- GammaPod Registry and Quality of Life NomogramRecruiting · University of Maryland, Baltimore · Bel Air, Maryland
- Microbiome and Association With Implant InfectionsPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- Correlation of Clinical Response to Pathologic Response in Patients With Early Breast CancerPHASE2 · Recruiting · Baylor Breast Care Center · Houston, Texas